High opioid dose escalation to 100 and 200 mg per day in patients with long term opioid therapy: Sex difference

Background It was reported that the risk of opioid overdose death increased with increasing opioid dose and little is known whether sex difference influences the risk of opioid dose escalation or overdose. Objective This study examined the relationship between sex difference and opioid dose escal...

Full description

Bibliographic Details
Main Authors: Zin, Che Suraya, Taufek, Nor Hidayah, Alias, Nor Elina, Meor Ahmad, Mazlila
Format: Proceeding Paper
Language:English
English
Published: 2019
Subjects:
Online Access:http://irep.iium.edu.my/71731/
http://irep.iium.edu.my/71731/1/190420_aseaps_irep_docx.pdf
http://irep.iium.edu.my/71731/2/190320-Poster_aseap_csz.pdf
_version_ 1848787501856063488
author Zin, Che Suraya
Taufek, Nor Hidayah
Alias, Nor Elina
Meor Ahmad, Mazlila
author_facet Zin, Che Suraya
Taufek, Nor Hidayah
Alias, Nor Elina
Meor Ahmad, Mazlila
author_sort Zin, Che Suraya
building IIUM Repository
collection Online Access
description Background It was reported that the risk of opioid overdose death increased with increasing opioid dose and little is known whether sex difference influences the risk of opioid dose escalation or overdose. Objective This study examined the relationship between sex difference and opioid dose escalation in patients with long term opioid therapy. Setting and participants This retrospective cohort study was conducted at tertiary hospital settings in Malaysia using electronic prescription records. Patients with long term opioid therapy of ≥90 days of opioid prescriptions and aged ≥18 years old with at least one opioid prescription (buprenorphine, morphine, oxycodone, fentanyl, dihydrocodeine and tramadol) between 1st January 2011, and 31st December 2016 were included. Follow-up was started from patients’ first opioid prescription until discontinuation of therapy, death from any cause or the end of the study period, with no interval of 120 days between the successive prescriptions. The risk of high opioid dose escalation to ≥100 mg/day and ≥200 mg/day relative to men and women was measured using a Cox proportional hazard model which was controlled for the effect of age. The adjusted hazard ratios and 95% Confidence Intervals (CIs) were used to summarize the risk of dose escalation using Stata v15.1 Results A total of 4688 patients with long term opioid therapy were identified. Of these, 248 (5.29%) escalated to high opioid doses of ≥100mg/day and 69 (1.47%) escalated to ≥200mg/day. The median time at risk to reach ≥100 and ≥200 mg/day was 126 days for men and 162 days for women. After adjusted for age, men were more likely than women to be escalated to high-dose opioid therapy of ≥100 mg/day (adjusted hazard ratio 2.32; 95% CI 1.79 to 3.00, p<0.0001) and ≥200 mg/day (adjusted hazard ratio 6.10; 95% CI 3.39 to 10.98, p<0.0001). Conclusions The risk of opioid dose escalation was different between men and women in which men are at higher risk than women for escalation to high-dose opioid therapy. Further research is necessary to understand the factors contributing to the observed differences and its association with clinical outcomes.
first_indexed 2025-11-14T17:25:56Z
format Proceeding Paper
id iium-71731
institution International Islamic University Malaysia
institution_category Local University
language English
English
last_indexed 2025-11-14T17:25:56Z
publishDate 2019
recordtype eprints
repository_type Digital Repository
spelling iium-717312019-04-22T07:56:37Z http://irep.iium.edu.my/71731/ High opioid dose escalation to 100 and 200 mg per day in patients with long term opioid therapy: Sex difference Zin, Che Suraya Taufek, Nor Hidayah Alias, Nor Elina Meor Ahmad, Mazlila RM147 Administration of Drugs and Other Therapeutic Agents Background It was reported that the risk of opioid overdose death increased with increasing opioid dose and little is known whether sex difference influences the risk of opioid dose escalation or overdose. Objective This study examined the relationship between sex difference and opioid dose escalation in patients with long term opioid therapy. Setting and participants This retrospective cohort study was conducted at tertiary hospital settings in Malaysia using electronic prescription records. Patients with long term opioid therapy of ≥90 days of opioid prescriptions and aged ≥18 years old with at least one opioid prescription (buprenorphine, morphine, oxycodone, fentanyl, dihydrocodeine and tramadol) between 1st January 2011, and 31st December 2016 were included. Follow-up was started from patients’ first opioid prescription until discontinuation of therapy, death from any cause or the end of the study period, with no interval of 120 days between the successive prescriptions. The risk of high opioid dose escalation to ≥100 mg/day and ≥200 mg/day relative to men and women was measured using a Cox proportional hazard model which was controlled for the effect of age. The adjusted hazard ratios and 95% Confidence Intervals (CIs) were used to summarize the risk of dose escalation using Stata v15.1 Results A total of 4688 patients with long term opioid therapy were identified. Of these, 248 (5.29%) escalated to high opioid doses of ≥100mg/day and 69 (1.47%) escalated to ≥200mg/day. The median time at risk to reach ≥100 and ≥200 mg/day was 126 days for men and 162 days for women. After adjusted for age, men were more likely than women to be escalated to high-dose opioid therapy of ≥100 mg/day (adjusted hazard ratio 2.32; 95% CI 1.79 to 3.00, p<0.0001) and ≥200 mg/day (adjusted hazard ratio 6.10; 95% CI 3.39 to 10.98, p<0.0001). Conclusions The risk of opioid dose escalation was different between men and women in which men are at higher risk than women for escalation to high-dose opioid therapy. Further research is necessary to understand the factors contributing to the observed differences and its association with clinical outcomes. 2019 Proceeding Paper NonPeerReviewed application/pdf en http://irep.iium.edu.my/71731/1/190420_aseaps_irep_docx.pdf application/pdf en http://irep.iium.edu.my/71731/2/190320-Poster_aseap_csz.pdf Zin, Che Suraya and Taufek, Nor Hidayah and Alias, Nor Elina and Meor Ahmad, Mazlila (2019) High opioid dose escalation to 100 and 200 mg per day in patients with long term opioid therapy: Sex difference. In: 8th Congress of the Association of South-East Asian Pain Societies (ASEAPS) 2019, 11th-14th April 2019, Kuching, Sarawak Malaysia. http://www.aseaps2019.com/eposter_view.php?catID=OT&fileName=ABST031_OT_OT03.pdf
spellingShingle RM147 Administration of Drugs and Other Therapeutic Agents
Zin, Che Suraya
Taufek, Nor Hidayah
Alias, Nor Elina
Meor Ahmad, Mazlila
High opioid dose escalation to 100 and 200 mg per day in patients with long term opioid therapy: Sex difference
title High opioid dose escalation to 100 and 200 mg per day in patients with long term opioid therapy: Sex difference
title_full High opioid dose escalation to 100 and 200 mg per day in patients with long term opioid therapy: Sex difference
title_fullStr High opioid dose escalation to 100 and 200 mg per day in patients with long term opioid therapy: Sex difference
title_full_unstemmed High opioid dose escalation to 100 and 200 mg per day in patients with long term opioid therapy: Sex difference
title_short High opioid dose escalation to 100 and 200 mg per day in patients with long term opioid therapy: Sex difference
title_sort high opioid dose escalation to 100 and 200 mg per day in patients with long term opioid therapy: sex difference
topic RM147 Administration of Drugs and Other Therapeutic Agents
url http://irep.iium.edu.my/71731/
http://irep.iium.edu.my/71731/
http://irep.iium.edu.my/71731/1/190420_aseaps_irep_docx.pdf
http://irep.iium.edu.my/71731/2/190320-Poster_aseap_csz.pdf